Speeding the time-to-clinic with Optimer®
New research shows how Optimer can speed projects by up to 75% compared to standard antibodies. Speeding project timelines can be vital to the development of any life science product. Whether…
New research shows how Optimer can speed projects by up to 75% compared to standard antibodies. Speeding project timelines can be vital to the development of any life science product. Whether…
As part of the Biologics Europe digital conference our CTO, Dr David Bunka, was invited to present as part of Sartorius’ workshop in the ‘Protein Engineering, Protein & Antibody…
Aptamer Technology Platform We develop aptamers (short, synthetic DNA- or RNA-based molecules) under strict laboratory conditions using our automated high-throughput selection platform. Aptamers have flexible, sequence-specific structures that…